SCS
CELG

Syquant Capital SAS’s Celgene Corp CELG Stock Holding History

Syquant Capital SAS’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-619,700
Closed -$61.5M – 30
2019
Q3 		$61.5M Buy
619,700
+239,800
+63% +$22.8M 16.85% 2
2019
Q2 		$35.1M Buy
+379,900
New +$36.1M 11.27% 3

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Syquant Capital SAS's CELG Position: Q4 2019 in Review

Syquant Capital SAS sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 619,700 shares — an estimated $61.5M sold.

Syquant Capital SAS first reported a position in CELG in Q2 2019 and held it in 2 quarters. The position peaked at $61.5M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Syquant Capital SAS reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Syquant Capital SAS sold 619,700 Celgene Corp shares in Q4 2019, an estimated $61.5M.
  • Syquant Capital SAS first reported a position in Celgene Corp in Q2 2019 and held it in 2 quarters.
  • Syquant Capital SAS's Celgene Corp position peaked at $61.5M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Syquant Capital SAS's 13F filing for Q4 2019, filed 8 Jan 2020.